HIV/AIDS :LIFE EXPECTANCY MORE IN HIV PATIENTS IF ARV MEDICINES STARTED AS SOON AS POSSIBLE AS VIRUS IS DETECTED OR IT IS ABOVE CD4 COUNT 350.
HIV/AIDS :LIFE EXPECTANCY MORE IN HIV PATIENTS IF ARV MEDICINES STARTED AS SOON AS POSSIBLE AS VIRUS IS DETECTED OR IT IS ABOVE CD4 COUNT 350.
PROF.DRRAM ,HIV/AIDS,SEX DIS.,SEX WEAK.& ABORTION SPECIALIST
profdrram@gmail.com,+917838059592,+919832025033,DELHI –NCR,IND
HIV/ AIDS,CANCER LATEST MEDICINES AVAILABLE AT CHEAP RATE.
FOLLOW ON FACE BOOK:www.facebook.com/drramkumar
FOLLOW ON TWITTER:www.twitter.com/profdrram
.
The decision to start treatment is different for every person with HIV and is a conversation best had with one's doctor. But research consistently finds that one of the benefits of starting HIV treatment as early as possible may be a longer life. In fact, a new study from the U.S. shows that, for people who start treatment before their CD4+ count falls below 350, their average life expectancy can be equal to -- or, in some cases, even higher than -- that of the general population.
For a disease that was once considered a death sentence, this is huge news, especially because life expectancy and mortality are often on the mind of people newly diagnosed with HIV and those considering starting treatment.As such neews will remove doubt from their mind that what is role of HIV ARV MEDICINES,they will be convinced that they will lead almost anormal life expectancy with regular treatment from early detection time and keeping their viral load minimum irrespective of what being their cd4 count and chance of transmission to sex partner or health personne and rlatives is also low if viral load is minimum.
Meanwhile, a second recent study looked at death rates for non-AIDS-defining illnesses among people who started HIV treatment when they had a CD4+ count above 350. It found that the non-AIDS death rate was not, and had never been, any higher than among a comparable group of HIV-negative people.
There are a lot of other factors that go into mortality rates, including illicit drug use (which has been shown to seriously cut into the average lifespan) and history of other illnesses. While these studies definitely show some good news regarding starting HIV meds early, many factors should go into the decision to start treatment, so consultation with physician and availability of medicines,physical clinical condition and economy will determine the treatment. — with AidsControl Empl India and 19 others. (4 photos)
PROF.DRRAM ,HIV/AIDS,SEX DIS.,SEX WEAK.& ABORTION SPECIALIST
profdrram@gmail.com,+917838059592,+919832025033,DELHI –NCR,IND
HIV/ AIDS,CANCER LATEST MEDICINES AVAILABLE AT CHEAP RATE.
FOLLOW ON FACE BOOK:www.facebook.com/drramkumar
FOLLOW ON TWITTER:www.twitter.com/profdrram
.
The decision to start treatment is different for every person with HIV and is a conversation best had with one's doctor. But research consistently finds that one of the benefits of starting HIV treatment as early as possible may be a longer life. In fact, a new study from the U.S. shows that, for people who start treatment before their CD4+ count falls below 350, their average life expectancy can be equal to -- or, in some cases, even higher than -- that of the general population.
For a disease that was once considered a death sentence, this is huge news, especially because life expectancy and mortality are often on the mind of people newly diagnosed with HIV and those considering starting treatment.As such neews will remove doubt from their mind that what is role of HIV ARV MEDICINES,they will be convinced that they will lead almost anormal life expectancy with regular treatment from early detection time and keeping their viral load minimum irrespective of what being their cd4 count and chance of transmission to sex partner or health personne and rlatives is also low if viral load is minimum.
Meanwhile, a second recent study looked at death rates for non-AIDS-defining illnesses among people who started HIV treatment when they had a CD4+ count above 350. It found that the non-AIDS death rate was not, and had never been, any higher than among a comparable group of HIV-negative people.
There are a lot of other factors that go into mortality rates, including illicit drug use (which has been shown to seriously cut into the average lifespan) and history of other illnesses. While these studies definitely show some good news regarding starting HIV meds early, many factors should go into the decision to start treatment, so consultation with physician and availability of medicines,physical clinical condition and economy will determine the treatment. — with AidsControl Empl India and 19 others. (4 photos)
Comments
Post a Comment